Crinetics Pharmaceuticals (CRNX) Amortizatization of Intangibles (2019 - 2025)
Historic Amortizatization of Intangibles for Crinetics Pharmaceuticals (CRNX) over the last 7 years, with Q3 2025 value amounting to $3.6 million.
- Crinetics Pharmaceuticals' Amortizatization of Intangibles rose 250.5% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 1743.31%. This contributed to the annual value of $14.9 million for FY2024, which is 13809.6% up from last year.
- Per Crinetics Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $3.6 million for Q3 2025, which was up 250.5% from $4.7 million recorded in Q2 2025.
- Crinetics Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $4.7 million during Q2 2025, with a 5-year trough of -$322000.0 in Q1 2022.
- Its 5-year average for Amortizatization of Intangibles is $1.8 million, with a median of $911000.0 in 2023.
- As far as peak fluctuations go, Crinetics Pharmaceuticals' Amortizatization of Intangibles tumbled by 28795.18% in 2022, and later soared by 92108.26% in 2023.
- Over the past 5 years, Crinetics Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$186000.0 in 2021, then skyrocketed by 288.71% to $351000.0 in 2022, then soared by 921.08% to $3.6 million in 2023, then rose by 16.16% to $4.2 million in 2024, then decreased by 13.5% to $3.6 million in 2025.
- Its Amortizatization of Intangibles stands at $3.6 million for Q3 2025, versus $4.7 million for Q2 2025 and $4.4 million for Q1 2025.